Cite

HARVARD Citation

    Wu, H. et al. (2022). Cytarabine delivered by CD44 and bone targeting redox-sensitive liposomes for treatment of acute myelogenous leukemia. Regenerative biomaterials. p. . [Online]. 
  
Back to record